Cargando…
Interventional therapies for secondary and essential hypertension /
This book aims to describe the role of interventional therapies in various forms of secondary hypertension and to explain the ability of such approaches to address unmet needs in the setting of uncontrolled essential hypertension. The coverage encompasses interventions in the full range of relevant...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Switzerland :
Springer,
2016.
|
| Colección: | Updates in hypertension and cardiovascular protection.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Foreword; Preface; Contents; Part I: Interventions for Secondary Hypertension; 1: Interventions for Renovascular Hypertension; 1.1 Introduction; 1.2 Indications for Intervention; 1.3 How Do the Study Results Look Like?; 1.3.1 Impact of Revascularization on BP Control; 1.3.2 Impact of Revascularization on Renal Function; 1.3.3 Impact of Revascularization on Survival; 1.3.4 Indications for PTRA; 1.3.5 Contraindications Against PTRA; 1.4 How to Diagnose a Hemodynamically Significant RAS; 1.5 Procedural Aspects; 1.5.1 Techniques and Devices for Endovascular Treatment of RAS
- 1.5.2 Pre- und Postprocedure Medication1.5.3 Access Route; 1.5.3.1 Femoral Access; 1.5.3.2 Brachial or Radial Access; 1.5.4 Preprocedural Angiography; 1.5.5 Procedure; 1.5.5.1 Atherosclerotic RAS; 1.5.5.2 Dedicated Interventional Tools; 1.5.5.3 Nonatherosclerotic RAS; 1.5.6 Postprocedural Follow-Up; 1.5.7 Potential Risks of the Procedure; 1.5.8 Recommended Equipment Checklist; 1.6 Patient Follow-Up; References; 2: Primary Aldosteronism: A Field on the Move; 2.1 Introduction; 2.2 Importance of Detecting Primary Aldosteronism in the Interventional Era
- 2.3 The Magnitude and the Consequences of the Problem2.3.1 Prevalence; 2.3.2 Cardiovascular Consequences; 2.4 Diagnosis; 2.5 Screening; 2.5.1 Who to Screen; 2.5.2 Aldosterone to Renin Ratio (ARR); 2.5.3 Expert Comment; 2.6 Confirmation; 2.6.1 Oral Sodium Load; 2.6.2 Intravenous Saline Load; 2.6.3 Fludrocortisone Test; 2.6.4 Captopril Test; 2.6.5 Expert Comment; 2.7 Localization; 2.7.1 Adrenal Venous Sampling; 2.7.2 Adrenal Imaging; 2.7.3 Nuclear Imaging; 2.7.4 Expert Comment; 2.8 Management and Follow-Up; 2.8.1 Adrenalectomy; 2.8.2 Mineralocorticoid Receptor Antagonists
- 2.8.3 Adrenalectomy Versus Medical Therapy2.9 Diagnostic and Therapeutic Algorithm; 2.9.1 Alternative Diagnostic Algorithms; 2.9.2 Expert Comment; Conclusion; References; 3: Pheochromocytoma/Paragangliomas; 3.1 Introduction; 3.2 Clinical Aspects; 3.3 Diagnosis; 3.3.1 Laboratory Findings; 3.3.2 Anatomical Imaging; 3.3.3 Functional Imaging; 3.4 Treatment; 3.4.1 Medical; 3.4.2 Surgical; 3.4.3 Palliative Therapy; 3.5 Follow-Up; References; 4: Coarctation of the Aorta; 4.1 Clinical Presentation and Diagnosis; 4.2 Indications for Intervention; 4.3 Therapy; 4.4 Surgical Treatment
- 4.5 Transcatheter Therapies4.6 Repair of Thoracic Pseudoaneurysms Late After Coarctation Repair; 4.7 Long-Term Outcomes; 4.8 Medical Management of Systemic Arterial Hypertension; 4.9 Surgical Versus Percutaneous Treatment; 4.10 Follow-Up; References; Part II: Adjunctive Therapies; 5: Sleep Apnea; 5.1 Introduction; 5.2 OSAS and BP Levels; 5.3 Epidemiological Evidence of the Association Between OSAS and Hypertension; 5.4 Proposed Mechanisms for OSAS-Related Hypertension; 5.5 Prognostic Relevance of OSAS-Related Hypertension